XRAY or MMSI: Which Is the Better Value Stock Right Now?

Core Insights - Dentsply International (XRAY) is currently viewed as a better value investment compared to Merit Medical (MMSI) based on various financial metrics and analyst outlooks [1][3][7] Valuation Metrics - XRAY has a forward P/E ratio of 8.73, significantly lower than MMSI's forward P/E of 28.03, indicating XRAY may be undervalued [5] - The PEG ratio for XRAY is 1.18, while MMSI's PEG ratio is 2.73, suggesting XRAY has a more favorable earnings growth outlook relative to its price [5] - XRAY's P/B ratio stands at 1.64, compared to MMSI's P/B of 3.89, further indicating XRAY's superior valuation [6] Analyst Ratings - XRAY holds a Zacks Rank of 2 (Buy), while MMSI has a Zacks Rank of 3 (Hold), reflecting a more positive earnings estimate revision for XRAY [3][7] - Based on the combination of earnings outlook and valuation metrics, XRAY is positioned as the superior value option in the medical-dental supplies sector [7]